Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosisD. H. Miller, Jack H. Simon, Paul S. Albert et al.|Annals of Neurology|1996Cited by 444
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trialBob W. van Oosten, Chris H. Polman, Mitchell K.P. Lai et al.|Neurology|1997Cited by 268
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Vincent Van Pesch, Stella Hughes et al.|JAMA Neurology|2023Cited by 62
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidenceCelia Oreja‐Guevara, Bassem Yamout, Wallace Brownlee et al.|Multiple Sclerosis and Related Disorders|2022Cited by 44
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple SclerosisJannis Müller, Tomáš Kalinčík, Francesco Patti et al.|JAMA Neurology|2025Cited by 43